The HAS-BLED Score Identifies Patients with Acute Venous Thromboembolism at High Risk of Major Bleeding Complications during the First Six Months of Anticoagulant Treatment

• Judith Kooiman ,

  * E-mail: j.kooiman@lumc.nl

  Affiliation Department of Thrombosis and Haemostasis, Leiden University Medical Center, Leiden, The Netherlands

  ⨯
• Nadja van Hagen,

  Affiliation Department of Thrombosis and Haemostasis, Leiden University Medical Center, Leiden, The Netherlands

  ⨯
• Antonio Iglesias del Sol,

  Affiliation Department of Internal Medicine, Rijnland Hospital, Leiderdorp, The Netherlands

  ⨯
• Erwin V. Planken,

  Affiliation Department of Internal Medicine, Diaconessenhuis, Leiden, The Netherlands

  ⨯
• Gregory Y. H. Lip,

  Affiliation University of Birmingham Centre for Cardiovascular Sciences, City Hospital, Birmingham, United Kingdom

  ⨯
• Felix J. M. van der Meer,

  Affiliation Department of Thrombosis and Haemostasis, Leiden University Medical Center, Leiden, The Netherlands

  ⨯
• Suzanne C. Cannegieter,

  Affiliations Department of Thrombosis and Haemostasis, Leiden University Medical Center, Leiden, The Netherlands, Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands

  ⨯
• Frederikus A. Klok,

  Affiliation Department of Thrombosis and Haemostasis, Leiden University Medical Center, Leiden, The Netherlands

  ⨯
• Menno V. Huisman

  Affiliation Department of Thrombosis and Haemostasis, Leiden University Medical Center, Leiden, The Netherlands

  ⨯